Health Catalyst (HCAT) Insider Trading & Ownership $7.09 +0.12 (+1.72%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Health Catalyst (NASDAQ:HCAT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.50%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$841,105.40 Get HCAT Insider Trade Alerts Want to know when executives and insiders are buying or selling Health Catalyst stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address HCAT Insider Buying and Selling by Quarter Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Health Catalyst Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/16/2024Linda LlewelynInsiderSell6,442$7.88$50,762.96 12/6/2024Benjamin LandryGeneral CounselSell19,268$8.32$160,309.76 12/6/2024Jason AlgerCFOSell19,599$8.32$163,063.68 12/2/2024Kevin Lee FreemanInsiderSell7,500$8.94$67,050.00 11/5/2024Daniel LesueurCOOSell5,209$7.70$40,109.30 10/15/2024Linda LlewelynInsiderSell1,324$8.16$10,803.84 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 10/3/2024Daniel LesueurCOOSell5,209$7.68$40,005.12 9/16/2024Linda LlewelynInsiderSell1,324$8.43$11,161.32 9/6/2024Benjamin LandryGeneral CounselSell2,466$7.39$18,223.74 9/6/2024Jason AlgerCFOSell2,899$7.39$21,423.61 9/4/2024Daniel LesueurCOOSell8,137$7.58$61,678.46 9/3/2024Kevin Lee FreemanInsiderSell7,500$7.22$54,150.00 8/15/2024Linda LlewelynInsiderSell1,328$6.57$8,724.96 8/5/2024Daniel LesueurCOOSell5,209$6.19$32,243.71 7/15/2024Linda LlewelynInsiderSell1,290$6.51$8,397.90 7/3/2024Daniel LesueurCOOSell5,208$6.15$32,029.20 5/15/2024Linda LlewelynInsiderSell2,066$7.00$14,462.00 4/15/2024Linda LlewelynInsiderSell2,005$6.11$12,250.55 1/16/2024Linda LlewelynInsiderSell3,163$10.83$34,255.29 (Data available from 1/1/2013 forward) HCAT Insider Trading Activity - Frequently Asked Questions Who is on Health Catalyst's Insider Roster? The list of insiders at Health Catalyst includes Benjamin Landry, Bryan Richard Hinton, Bryan Truman Hunt, Daniel D Burton, Daniel H Orenstein, Daniel Lesueur, Duncan Gallagher, Jason Alger, Kevin Lee Freeman, Linda Llewelyn, and Paul Horstmeier. Learn more on insiders at HCAT. What percentage of Health Catalyst stock is owned by insiders? 2.50% of Health Catalyst stock is owned by insiders. Learn more on HCAT's insider holdings. Which Health Catalyst insiders have been buying company stock? The following insider purchased HCAT shares in the last 24 months: Daniel D Burton ($499,819.50). How much insider buying is happening at Health Catalyst? Insiders have purchased a total of 49,050 HCAT shares in the last 24 months for a total of $499,819.50 bought. Which Health Catalyst insiders have been selling company stock? The following insiders have sold HCAT shares in the last 24 months: Benjamin Landry ($217,759.72), Bryan Truman Hunt ($32,460.00), Daniel Lesueur ($206,065.79), Jason Alger ($254,579.49), Kevin Lee Freeman ($121,200.00), and Linda Llewelyn ($198,961.73). How much insider selling is happening at Health Catalyst? Insiders have sold a total of 124,371 Health Catalyst shares in the last 24 months for a total of $1,031,026.73 sold. Health Catalyst Key ExecutivesMr. Daniel D. Burton (Age 48)CEO & Director Compensation: $158.9kMr. Daniel H. Orenstein (Age 54)Senior Advisor Compensation: $356.56kMr. Kevin Freeman (Age 51)Chief Commercial Officer Compensation: $405.9k2 recent tradesMr. Jason Alger (Age 40)CFO & Chief Accounting Officer 2 recent tradesMr. Daniel LeSueurChief Operating Officer5 recent tradesMr. Dave RossChief Technology OfficerMr. Adam BrownSenior Vice President of Investor Relations and Financial Planning & AnalysisMr. Benjamin LandryGeneral Counsel & Secretary of the Board2 recent tradesMs. Tarah Neujahr BryanChief Marketing & Communications OfficerMr. Kyle J. SalyersChief Strategy Officer & Senior VP of Corporate Development More Insider Trading Tools from MarketBeat Related Companies N-able Insider Transactions Certara Insider Transactions PagerDuty Insider Transactions Endava Insider Transactions Integral Ad Science Insider Transactions MeridianLink Insider Transactions Grid Dynamics Insider Transactions Matterport Insider Transactions Sabre Insider Transactions Zuora Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:HCAT) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health Catalyst, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Health Catalyst With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
